1. Home
  2. OVID vs MTEX Comparison

OVID vs MTEX Comparison

Compare OVID & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • MTEX
  • Stock Information
  • Founded
  • OVID 2014
  • MTEX 1993
  • Country
  • OVID United States
  • MTEX United States
  • Employees
  • OVID N/A
  • MTEX N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • MTEX Medicinal Chemicals and Botanical Products
  • Sector
  • OVID Health Care
  • MTEX Health Care
  • Exchange
  • OVID Nasdaq
  • MTEX Nasdaq
  • Market Cap
  • OVID 20.6M
  • MTEX 20.0M
  • IPO Year
  • OVID 2017
  • MTEX 1999
  • Fundamental
  • Price
  • OVID $0.33
  • MTEX $8.98
  • Analyst Decision
  • OVID Strong Buy
  • MTEX
  • Analyst Count
  • OVID 4
  • MTEX 0
  • Target Price
  • OVID $3.13
  • MTEX N/A
  • AVG Volume (30 Days)
  • OVID 1.7M
  • MTEX 11.0K
  • Earning Date
  • OVID 08-12-2025
  • MTEX 08-12-2025
  • Dividend Yield
  • OVID N/A
  • MTEX N/A
  • EPS Growth
  • OVID N/A
  • MTEX N/A
  • EPS
  • OVID N/A
  • MTEX N/A
  • Revenue
  • OVID $548,000.00
  • MTEX $115,036,000.00
  • Revenue This Year
  • OVID N/A
  • MTEX N/A
  • Revenue Next Year
  • OVID $5.32
  • MTEX N/A
  • P/E Ratio
  • OVID N/A
  • MTEX N/A
  • Revenue Growth
  • OVID 15.61
  • MTEX N/A
  • 52 Week Low
  • OVID $0.24
  • MTEX $6.75
  • 52 Week High
  • OVID $1.47
  • MTEX $16.49
  • Technical
  • Relative Strength Index (RSI)
  • OVID 55.40
  • MTEX 46.49
  • Support Level
  • OVID $0.29
  • MTEX $8.69
  • Resistance Level
  • OVID $0.35
  • MTEX $11.36
  • Average True Range (ATR)
  • OVID 0.03
  • MTEX 0.67
  • MACD
  • OVID 0.00
  • MTEX -0.04
  • Stochastic Oscillator
  • OVID 74.23
  • MTEX 28.46

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

Share on Social Networks: